Randomized, double blind, placebo controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of lung function, mucus plugging and other lung imaging parameters in patients with asthma
Latest Information Update: 08 May 2025
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms VESTIGE
- Sponsors Sanofi
Most Recent Events
- 01 May 2025 According to Regeneron pharmaceuticals media release, data from this study will be presented at the American Thoracic Society (ATS) International Conference 2025 being held from May 18 to 21 in San Francisco, California.
- 06 Feb 2025 According to Sanofi media release, data from this trial will be presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
- 26 Aug 2024 According to Regeneron pharmaceuticals media release, the company will be presented at the European Respiratory Society (ERS) Congress 2024 being held from September 7 to 11 in Vienna, Austria.